Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/v13030532

http://scihub22266oqcxt.onion/10.3390/v13030532
suck pdf from google scholar
33807095!8004704!33807095
unlimited free pdf from europmc33807095    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33807095      Viruses 2021 ; 13 (3): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing #MMPMID33807095
  • Tomar PPS; Krugliak M; Arkin IT
  • Viruses 2021[Mar]; 13 (3): ä PMID33807095show ga
  • The etiological agent of the COVID-19 pandemic is SARS-CoV-2. As a member of the Coronaviridae, the enveloped pathogen has several membrane proteins, of which two, E and 3a, were suggested to function as ion channels. In an effort to increase our treatment options, alongside providing new research tools, we have sought to inhibit the 3a channel by targeted drug repurposing. To that end, using three bacteria-based assays, we screened a library of 2839 approved-for-human-use drugs and identified the following potential channel-blockers: Capreomycin, Pentamidine, Spectinomycin, Kasugamycin, Plerixafor, Flumatinib, Litronesib, Darapladib, Floxuridine and Fludarabine. The stage is now set for examining the activity of these compounds in detailed electrophysiological studies and their impact on the whole virus with appropriate biosafety measures.
  • |*Drug Repositioning[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19/*virology[MESH]
  • |Drug Evaluation, Preclinical[MESH]
  • |Humans[MESH]
  • |SARS-CoV-2/*drug effects/genetics/metabolism[MESH]
  • |Viral Envelope Proteins/*antagonists & inhibitors/genetics/*metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box